Conversion therapy for intrahepatic cholangiocarcinoma and tumor downsizing to increase resection rates: A systematic review

Shaib, 2004, The epidemiology of cholangiocarcinoma, Semin Liver Dis, 24, 115, 10.1055/s-2004-828889 Weber, 2015, Intrahepatic cholangiocarcinoma: expert consensus statement, HPB (Oxford), 17, 669, 10.1111/hpb.12441 Koh, 2005, Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma, Am J Surg, 189, 120, 10.1016/j.amjsurg.2004.03.018 Nathan, 2009, A proposed staging system for intrahepatic cholangiocarcinoma, Ann Surg Oncol, 16, 14, 10.1245/s10434-008-0180-z Aljiffry, 2009, Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature, J Am Coll Surg, 208, 134, 10.1016/j.jamcollsurg.2008.09.007 Berthiaume, 2004, The molecular pathogenesis of cholangiocarcinoma, Semin Liver Dis, 24, 127, 10.1055/s-2004-828890 Razumilava, 2014, Cholangiocarcinoma, Lancet, 383, 2168, 10.1016/S0140-6736(13)61903-0 Sia, 2013, Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies, Oncogene, 32, 4861, 10.1038/onc.2012.617 Bragazzi, 2011, Cholangiocarcinoma: epidemiology and risk factors, Transl Gastrointest Cancer, 1, 21 Chen, 2001, Intraductal papillary neoplasia of the liver associated with hepatolithiasis, Hepatology, 34, 651, 10.1053/jhep.2001.28199 Kim, 1989, Intraductal variant of peripheral cholangiocarcinoma of the liver with Clonorchis sinensis infection, Cancer, 63, 1562, 10.1002/1097-0142(19890415)63:8<1562::AID-CNCR2820630819>3.0.CO;2-8 DeOliveira, 2007, Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution, Ann Surg, 245, 755, 10.1097/01.sla.0000251366.62632.d3 Patel, 2001, Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States, Hepatology, 33, 1353, 10.1053/jhep.2001.25087 Shaib, 2004, Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?, J Hepatol, 40, 472, 10.1016/j.jhep.2003.11.030 Singal, 2011, Intra-hepatic cholangiocarcinoma–frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center, J Cancer Res Clin Oncol, 137, 1071, 10.1007/s00432-010-0971-z 1997, 6 Dodson, 2013, Intrahepatic cholangiocarcinoma: management options and emerging therapies, J Am Coll Surg, 217, 736, 10.1016/j.jamcollsurg.2013.05.021 Guro, 2017, Multidisciplinary management of intrahepatic cholangiocarcinoma: current approaches, Surg Oncol, 26, 146, 10.1016/j.suronc.2017.03.001 Nathan, 2007, Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis, J Gastrointest Surg, 11, 1488, 10.1007/s11605-007-0282-0 Guglielmi, 2009, Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection, World J Surg, 33, 1247, 10.1007/s00268-009-9970-0 Lang, 2009, Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients, J Am Coll Surg, 208, 218, 10.1016/j.jamcollsurg.2008.10.017 Witzigmann, 2006, Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection, Ann Surg, 244, 230, 10.1097/01.sla.0000217639.10331.47 Bridgewater, 2014, Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma, J Hepatol, 60, 1268, 10.1016/j.jhep.2014.01.021 Meyer, 2000, Liver transplantation for cholangiocarcinoma: results in 207 patients, Transplantation, 69, 1633, 10.1097/00007890-200004270-00019 Ringe, 1989, The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence, Ann Surg, 209, 88, 10.1097/00000658-198901000-00013 Robles, 2004, Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma, Ann Surg, 239, 265, 10.1097/01.sla.0000108702.45715.81 Buettner, 2017, The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis, J Surg Oncol, 115, 312, 10.1002/jso.24524 Ghiringhelli, 2013, Hepatic arterial infusion of gemcitabine plus oxaliplatin as second-line treatment for locally advanced intrahepatic cholangiocarcinoma: preliminary experience, Chemotherapy, 59, 354, 10.1159/000362223 Kato, 2013, Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study, Ann Surg Oncol, 20, 318, 10.1245/s10434-012-2312-8 Mouli, 2013, Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis, J Vasc Interv Radiol, 24, 1227, 10.1016/j.jvir.2013.02.031 Poggi, 2008, Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report, Anticancer Res, 28, 2987 Rayar, 2015, Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment, Ann Surg Oncol, 22, 3102, 10.1245/s10434-014-4365-3 Schiffman, 2011, Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival, Ann Surg Oncol, 18, 431, 10.1245/s10434-010-1333-4 Servajean, 2014, One case of intrahepatic cholangiocarcinoma amenable to resection after radioembolization, World J Gastroenterol, 20, 5131, 10.3748/wjg.v20.i17.5131 Tran, 2015, Locally advanced intrahepatic cholangiocarcinoma: complete pathologic response to neoadjuvant chemotherapy followed by left hepatic trisectionectomy and caudate lobectomy, Dig Dis Sci, 60, 3226, 10.1007/s10620-015-3640-x Uji, 2016, A case of advanced intrahepatic cholangiocarcinoma accidentally, but successfully, treated with capecitabine plus oxaliplatin (CAPOX) therapy combined with bevacizumab: a case report, Surg Case Rep, 2, 63, 10.1186/s40792-016-0191-0 Wu, 2007, Locally advanced intrahepatic cholangiocarcinoma successfully resected after transcatheter arterial chemoembolization with degradable starch microspheres: report of a case, Hepatogastroenterology, 54, 1345 Primrose, 2019, Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomized controlled, multicenter phase 3 study, Lancet Oncol, 20, 663, 10.1016/S1470-2045(18)30915-X Edeline, 2013, Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting?, Ann Surg Oncol, 20, 2518, 10.1245/s10434-013-2906-9 Eckel, 2007, Emerging drugs for biliary cancer, Expert Opin Emerg Drugs, 12, 571, 10.1517/14728214.12.4.571 Khan, 2005, Cholangiocarcinoma, Lancet, 366, 1303, 10.1016/S0140-6736(05)67530-7 Facciuto, 2015, Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation, Transplantation, 99, 151, 10.1097/TP.0000000000000286 Ghali, 2005, Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience, Liver Transpl, 11, 1412, 10.1002/lt.20512 De Vreede, 2000, Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma, Liver Transplantation, 6, 309, 10.1053/lv.2000.6143 Rosen, 2010, Liver transplantation for cholangiocarcinoma, Transpl Int, 23, 692, 10.1111/j.1432-2277.2010.01108.x Hong, 2011, Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center, Arch Surg, 146, 683, 10.1001/archsurg.2011.116 Benson, 2017, NCCN guidelines insights: hepatobiliary Cancers, Version 1.2017, J Natl Compr Canc Netw 15, 563, 10.6004/jnccn.2017.0059 Gelli M., Le roy B., Serji B., et al. Neoadjuvant chemotherapy for intrahepatic cholangiocarcinoma: a new perspective for initially unresectable cases. HPB18:e849-e850.